Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Joseph J Larosa is EVP General Counsel and Secret at Regeneron Pharmaceuticals. OQRO lists 14 transactions filed with the SEC under this name, the latest on Nov 4, 2026, each linked to the official Form 4.
EVP General Counsel and Secret
Disclosures on record
14
Companies involved
1
As of the latest filing on , Joseph J Larosa reported holding 38,906 shares of Regeneron Pharmaceuticals (REGN), worth about $36.8M at the last close of $946 (Nov 18, 2026). In the last 12 months, Joseph J Larosa sold $4.31M in 2 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN | 38,906 | 39K direct | $946 | $36.8M | Nov 2, 2026 |
Is this Joseph J Larosa’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Regeneron PharmaceuticalsREGN
14 disclosures · Nov 2025 – Nov 2026 · 2 sold
Nov 2, 2026Sold~$3.8Mdisclosed Nov 4
DetailsOfficial recordNov 2, 2026Sold~$509Kdisclosed Nov 4
DetailsOfficial recordNov 2, 202612Kdisclosed Nov 4
DetailsOfficial recordNov 2, 202612Kdisclosed Nov 4
DetailsOfficial recordNov 2, 20268,686disclosed Nov 4
DetailsOfficial recordAug 19, 202612Kdisclosed Aug 21
DetailsOfficial recordAug 19, 202612Kdisclosed Aug 21
DetailsOfficial recordAug 19, 20269,019disclosed Aug 21
DetailsOfficial recordDec 5, 20252,476disclosed Dec 9
DetailsOfficial recordDec 5, 202512Kdisclosed Dec 9
DetailsOfficial recordDec 8, 20251,396disclosed Dec 9
DetailsOfficial recordNov 20, 202514Kdisclosed Nov 24
DetailsOfficial recordNov 20, 202514Kdisclosed Nov 24
DetailsOfficial recordNov 20, 202513Kdisclosed Nov 24
DetailsOfficial recordJoseph J Larosa has no open-market purchase on record since 2015. Sales in 6 of the 12 years since 2015.
Joseph J Larosa reported 0 open-market purchases and 84 sales since 2015; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $4.31M2×2 trades |
| 2024 | — | $6.8M5×5 trades |
| 2022 | — | $7.22M16×16 trades |
| 2021 | — | $4.24M4×4 trades |
| 2020 | — | $16.4M56×56 trades |
| 2015 | — | $8.24M1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Joseph J Larosa reported 0 open-market purchases and 84 sales here, 2015 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Nov 2, 2026, Joseph J Larosa reported holding 38,906 shares of Regeneron Pharmaceuticals (REGN). At the last close of $946 on Nov 18, 2026, that is about $36.8M. This is the stake disclosed in filings, not a net worth.
No public filing gives Joseph J Larosa's net worth. What SEC Form 4 shows is the stock stake: 38,906 shares of Regeneron Pharmaceuticals (REGN), about $36.8M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, Joseph J Larosa reported 2 open-market sales worth $4.31M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Joseph J Larosa has no open-market purchase on record since 2015. Sales in 6 of the 12 years since 2015.
In SEC filings since 2015: no open-market purchase is on record; the latest open-market sale is from 2026.
Regeneron Pharmaceuticals (REGN), from 2015 to 2026: 0 purchases and 84 sales.